What is the Org number of Vaccin i Norr AB?

Vaccin i Norr AB is registered with Bolagsverket / SCB under Org 5592187297.

What is the revenue of Vaccin i Norr AB?

Vaccin i Norr AB reported revenue of SEK 4,3M in 2024.

How many employees does Vaccin i Norr AB have?

Vaccin i Norr AB employs 2 people as of the latest annual report.

Who is the CEO of Vaccin i Norr AB?

Jonas Valdemar Lundberg is Chief Executive Officer of Vaccin i Norr AB, in role since 2020.

Who is the chairman of Vaccin i Norr AB?

Åke Fredrik Degerstedt chairs the board of Vaccin i Norr AB, in role since 2020.

Where is Vaccin i Norr AB headquartered?

Vaccin i Norr AB's registered address is Stationsgatan 13 C.

Riskpilot← Back to search

Sign inGet full access

Vaccin i Norr AB

ABActive

Org 5592187297Stationsgatan 13 C, 931 31 SkellefteåGeneral medical practice activities · NACE 8621Est. 20192 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2020	2021	2022	2023	2024
Revenue	1 659	15 020	7 601	5 044	4 325
Staff expenses	—	—	—	−1 399	−1 158
EBITDA	57	2 935	1 530	187	77
Depreciation & amort.	−0	−99	−145	−153	−139
EBIT	57	2 836	1 385	34	−62
Net financials	—	−2	−3	−9	−11
Profit before tax	57	2 102	1 019	41	17
Tax	−12	−453	−212	1	−13
Net profit	45	1 649	807	43	4

Balance sheet

SEK thousands

Item	2020	2021	2022	2023	2024
Total assets	220	6 216	3 640	3 268	3 334
Equity	95	1 744	1 351	1 394	1 398
Long-term debt	0	0	0	—	—
Short-term debt	125	3 739	1 194	794	947
Total debt	125	3 739	1 194	794	947

Financial ratios

5-year trend

EBITDA margin

1.8%

This company

15.8%

Market median

-89% vs market

20202024

Equity ratio

41.9%

This company

38.2%

Market median

+10% vs market

20202024

Return on equity

0.3%

This company

18.4%

Market median

-98% vs market

20202024

Net profit margin

0.1%

This company

8.1%

Market median

-99% vs market

20202024

Asset turnover

1.30×

This company

1.12×

Market median

+16% vs market

20202024

Debt / equity

1.38×

This company

0.62×

Market median

-123% vs market

20202024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
Annual report 2020
Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-12-31

Vaccin i Norr AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Vaccin i Norr AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Vaccin i Norr AB